amoxicillin
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Bioequivalence of Amoxicillin
Conditions
Bioequivalence of Amoxicillin
Trial Timeline
Feb 1, 2005 → Jul 1, 2005
NCT ID
NCT01933698About amoxicillin
amoxicillin is a approved stage product being developed by GSK plc for Bioequivalence of Amoxicillin. The current trial status is completed. This product is registered under clinical trial identifier NCT01933698. Target conditions include Bioequivalence of Amoxicillin.
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01933698 | Approved | Completed |
Competing Products
20 competing products in Bioequivalence of Amoxicillin